Feasibility Study of the FARAFLEX Mapping and PFA System

NCT06510556 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Persistent Atrial Fibrillation
Paroxysmal AF

Interventions

DEVICE: FARAFLEX Ablation Treatment
DEVICE: Commercial Sub-study Treatment

Sponsor

Boston Scientific Corporation